Pfizer
Nicole T. Fitting has extensive experience in the pharmaceutical and consulting industries, primarily with Pfizer since June 2004. Currently serving as Senior Director for Enterprise Learning Systems and Platforms, Nicole has held various leadership roles at Pfizer, including Director of the Enterprise Learning Management Systems Center of Excellence, Director of Strategic Integration, Director of Worldwide Technology, and Strategic Integration and Program/Project Lead. Prior to joining Pfizer, Nicole worked at Accenture from 1996 to 2004, where the position held was Manager.
This person is not in any teams
This person is not in any offices
Pfizer
616 followers
Pfizer Inc. is a research-based, global biopharmaceutical company. They apply science and their global resources to bring therapies to people that extend and significantly improve their lives through the discovery, development, manufacture, marketing, sale and distribution of biopharmaceutical products worldwide. They work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Pfizer collaborates with healthcare providers, governments and local communities to support and expand access to reliable, affordable healthcare around the world. Pfizer was founded in 1942. Most of Pfizer’s revenues come from the manufacture and sale of biopharmaceutical products. They believe that their medicines and vaccines provide significant value for healthcare providers and patients, through improved treatment of diseases, improvements in health, wellness and productivity as well as by reducing other healthcare costs, such as emergency room or hospitalization. Pfizer is committed to fulfilling their purpose: Breakthroughs that change patients’ lives. Their purpose fuels everything they do and reflects both their passion for science and commitment to patients. Pfizer’s growth strategy is driven by five “Bold Moves” that help them deliver breakthroughs for patients and create value for shareholders and other stakeholders: 1. Unleash the power of our people; 2. Deliver first-in-class science; 3. Transform our go-to-market model; 4. Win the digital race in pharma; and 5. Lead the conversation.